croup
CROUP
Croup is a viral infection that causes erythema and edema of the tracheal walls and narrowing of the subglottic region. It is often characterized by an acute, rapidly progressing respiratory disease.
It is a medical emergency in children and requiring immediate treatment.
Most common causes are parainfluenza virus 1&2 and respiratory syncytial virus.
Occurrence of symptoms is usually at night and with abrupt onset and improve during daytime.

Differential Diagnosis

Diphtheria
  • Characterized by malaise, sore throat, anorexia, & low-grade fever
  • W/in 2-3 days, pharyngeal exam may show a typical gray-white membrane adherent to the tissue that bleeds when attempted to be removed
  • W/ insidious course but sudden respiratory obstruction may occur
Epiglottitis
  • Characterized by sudden onset of high fever, dysphagia, drooling & anxious appearance
  • Patient prefers to sit forward in sniffing position
  • Barking cough is rarely observed
Tracheitis
  • Patient appears febrile, toxic & gives poor response to Epinephrine
Other Causes of Stridor
  • Foreign body
  • Retropharyngeal abscess
  • Hereditary angioedema
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.

Pearl Toh, 22 May 2016
Asthma patients on salmeterol, a long-acting beta-agonist (LABA), plus fluticasone inhaled corticosteroid (ICS) combination therapy did not have a greater risk of serious asthma-related events compared with patients receiving fluticasone alone, according to the recent AUSTRI* study.